Skip to main navigation
  • Contact Us
  • Investors
  • Media
  • Careers
    •
  • About Us
    • See the Difference
    • Leadership
    • History
    • Corporate Citizenship
    • Grants
    • Locations
  • Products
    • OverviewOverview
      • DEFINITY®
        • VIALMIX®
        • PINSYNC®
      • TechneLite®
      • Xenon-133
        • Calidose™ Dispenser System
      • NEUROLITE®
      • Thallium-201
      • QUADRAMET®
      • Cardiolite®
      • Gallium-67
      • Fludeoxyglucose F 18 Injection
    • Manufacturing & Supply Chain
    • Customer ServiceCustomer Service
      • FAQs
      • Standard Conditions of Sale
      • Reimbursement
  • Pipeline
    • Overview
      • Flurpiridaz F 18
      • CNA (LMI 1195)
      • VRI
      • Partnering
  • Art of Imaging
    • Overview
    • History of Innovation
    • Medical Imaging 101
    • Nuclear Imaging
    • Echocardiography
  • Investor Relations
    • Corporate Profile
    • Press Releases
    • SEC Filings
    • Corporate Governance
    • Board of Directors
    • Stock Information
    • Calendar of Events
    • Presentations
    • Information Requests
    • FAQ
    • IR Contact
    •
  • Contact Us
  • Investors
  • Media
  • Careers
    •

    Investor Relations

    Investor Relations

    • Investor Overview
    • Corporate Profile
    • Press Releases
    • SEC Filings
    • Supplemental Financial Information
    • Corporate Governance
    • Board of Directors
    • Stock Information
    • Calendar of Events
    • Presentations
    • Information Requests
    • FAQ
    • IR Contact

    Investor Toolkit

    • Print Page
    • RSS Feeds
    • E-mail Alerts

    IR Contact

    Phone: 978.671.8001
    E-mail: ir@lantheus.com
    • 
  • Contact Us
  • Privacy Policy
  • Legal Notice
  • Compliance
  • Suppliers/Vendors
  • Site Directory

    • © 2017 Lantheus Medical Imaging, Inc. All rights reserved.
    Intended for U.S. Residents only.

    331 Treble Cove Road, N. Billerica, MA 01862 Telephone: 1-800-362-2668

    Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy .